Chief Executive Officer Tim Wentworth
solidifies the Walgreens Boots Alliance Executive Committee
New executive appointments deepen healthcare
expertise, position company for accelerated growth and
profitability
- Mary Langowski joins WBA to lead U.S. Healthcare segment
- Manmohan Mahajan, interim since July 2023, appointed permanent
chief financial officer
- Elizabeth Burger joins WBA as chief human resources
officer
Walgreens Boots Alliance (Nasdaq: WBA) Chief Executive Officer
Tim Wentworth today announced updates to WBA’s Executive Committee
as the company advances a health services strategy rooted in its
retail pharmacy footprint.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240208862772/en/
Manmohan Mahajan, EVP and Global Chief
Financial Officer (Photo: Business Wire)
“Today’s announcement solidifies the leadership team that will
carry WBA into its future as we look to expand our reach beyond
neighborhood pharmacies into the fastest-growing areas of
healthcare,” said Wentworth. “We have a strong team with a track
record of operational excellence and an unwavering commitment to
the execution of our goals. The spirit of this leadership team is
one of collaboration, transparency and working effectively
together. We share a sharp focus on the important goals in front of
us, unlocking embedded profitability and reshaping our healthcare
strategy to deliver sustainable value for our stakeholders.”
Wentworth, with the support of the WBA Board of Directors,
has made the following leadership appointments:
Mary Langowski has been appointed executive vice
president and president, U.S. Healthcare. A nationally
recognized healthcare leader, Langowski brings a successful track
record of building and driving commercially successful initiatives,
businesses and partnerships that improve patient outcomes, lower
costs and unlock profitability within new models of care. Her
decades of experience span leading payer organizations, pharmacy,
retail healthcare services and providers as well as senior roles in
federal and state government.
Langowski joins WBA after serving as CEO of Solera Health, a
leading value-based technology business serving payers and
employers, since 2020. She was appointed CEO after serving as
Solera Health’s independent board director and has successfully
transformed the company with the launch of new condition product
lines, a new technology platform and a new economic model to
support sustained growth in the business. Prior to Solera,
Langowski served as executive vice president and chief strategy and
corporate development officer at CVS Health, where she helped lead
the organization’s evolution and execution as a healthcare company,
leading the foundational work for its healthcare services strategy
and key aspects of CVS’ acquisition of Aetna.
Langowski will lead WBA’s U.S. Healthcare segment as Walgreens
expands its role in healthcare, building on its strengths in
pharmacy to unlock new areas of profitable growth and bringing
high-value solutions to industry players, including payers, health
systems, PBMs and biopharma manufacturers.
Current executive vice president and president, U.S. Healthcare,
John Driscoll, will transition to a senior advisory role working
closely with Wentworth, Langowski and the U.S. Healthcare
business.
Manmohan Mahajan has been appointed executive vice
president and global chief financial officer (CFO). He has
served as interim global CFO since July 2023 and has played an
integral role in leading WBA’s growth and cost discipline efforts
aimed at aligning the company’s cost structure with business
performance. This includes a focused approach to increasing cash
flow across the company by lowering capital expenditures and
keeping the company on pace toward $1 billion in cost savings this
year.
Mahajan joined the company in 2016 and previously served as
senior vice president, global controller and chief accounting
officer. Prior to joining WBA, Mahajan served in positions of
increasing responsibility with GE Capital, a former subsidiary of
General Electric Company.
Elizabeth Burger has been appointed executive vice
president and chief human resources officer (CHRO). Prior to
joining WBA, Burger served as senior vice president, CHRO at
Flowserve, a leading provider of flow control products and services
for the global infrastructure markets. She formerly served as CHRO
with Hanesbrands Inc., the world’s largest manufacturer and
marketer of everyday basic apparel. She also previously worked at
Monsanto Company in various roles of increasing responsibility,
including senior vice president of global business operations.
Burger is a high-energy, results-oriented CHRO with more than 25
years of demonstrated business experience. She is known for
developing and implementing change strategies that position
businesses for growth.
Langowski, Mahajan and Burger will report directly to
Wentworth and join WBA’s current Executive Committee, which
includes:
Ornella Barra, executive vice president and chief
operating officer, International, WBA Barra oversees WBA’s
businesses outside of the United States, including Boots UK and
other pharmacy-led health and beauty retail businesses in Europe,
Latin America and Asia, as well as WBA’s pharmaceutical wholesale
operation in Germany and the No7 Beauty Company. She is also chair
of the Environmental, Social and Governance Committee.
Tracey Brown, executive vice president and president,
Walgreens retail and chief customer officer Brown is
responsible for Walgreens $30 billion retail business and consumer
experience across all retail, pharmacy and health consumer
touchpoints and leads strategies to advance Walgreens across a
complex and dynamic competitive landscape. She oversees more than
200,000 field and store operations team members, pharmacists,
merchandising, marketing, product, digital, omnichannel, store
format, data and analytics, asset protection, real estate and
supply chain organizations. She has more than 30 years of
experience driving business growth, operations, creating
omnichannel customer experiences and leveraging digital
capabilities to connect consumers and brands.
Neal Sample, executive vice president and chief
information officer, WBA Sample leads the strategy for WBA’s IT
function and the implementation of its technology and digital
innovation, with an emphasis on improving the digital experience
for customers and patients. Sample joined the company in October of
2023, bringing more than 20 years of deep experience across highly
regulated industries including healthcare, financial services and
consumer internet.
Rick Gates, senior vice president and chief pharmacy
officer, Walgreens With more than 25 years of experience as a
Walgreens pharmacist, Gates helps drive the company’s mission to
evolve the future of pharmacy in healthcare and broaden pharmacy
services. He and his team also play a critical role in aligning and
advancing the Walgreens pharmacy and specialty pharmacy businesses
across Walgreens, including the U.S. Healthcare business
segment.
Beth Leonard, senior vice president and chief
corporate affairs officer, WBA Leonard oversees a combined
corporate affairs team comprised of talented leaders who manage
Walgreens Government Relations, Public Affairs and Corporate
Communications functions. The team is responsible for
communications with key Walgreens stakeholders including employees,
media, industry partners and policymakers at the local, state and
federal levels.
Matt D’ambrosio, senior vice president and global
chief compliance and ethics officer, WBA D’ambrosio will
continue to serve as interim global chief legal officer. WBA
expects to announce a permanent global chief legal officer by the
end of February.
Each of the new Executive Committee members will assume their
roles in March. All U.S.-based Executive Committee members will be
based in the Chicagoland area.
“As I reflect on my first few months at WBA, what has impressed
me most is the experience, talent and vision of our leaders and
team members,” said Wentworth. “With the additions to our team,
this Executive Committee brings proven leadership and deep
experience in healthcare, culture and customer experience to
accelerate our growth and lead the next chapter of our company for
our team members, shareholders and most importantly the customers
and patients we serve.”
About Walgreens Boots Alliance Walgreens Boots Alliance
(Nasdaq: WBA) is an integrated healthcare, pharmacy and retail
leader serving millions of customers and patients every day, with a
170-year heritage of caring for communities. A trusted, global
innovator in retail pharmacy with approximately 12,500 locations
across the U.S., Europe and Latin America, WBA plays a critical
role in the healthcare ecosystem. The Company is reimagining local
healthcare and well-being for all as part of its purpose – to
create more joyful lives through better health. Through dispensing
medicines, improving access to a wide range of health services,
providing high quality health and beauty products and offering
anytime, anywhere convenience across its digital platforms, WBA is
shaping the future of healthcare.
WBA employs more than 330,000 people and has a presence in eight
countries through its portfolio of consumer brands: Walgreens,
Boots, Duane Reade, the No7 Beauty Company and Benavides in Mexico.
Additionally, WBA has a portfolio of healthcare-focused investments
located in several countries, including China and the U.S.
The Company is proud of its contributions to healthy
communities, a healthy planet, an inclusive workplace and a
sustainable marketplace. WBA has been recognized for its commitment
to operating sustainably: the Company is an index component of the
Dow Jones Sustainability Indices (DJSI) and was named to the 100
Best Corporate Citizens 2022.
More Company information is available at
www.walgreensbootsalliance.com.
(WBA-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240208862772/en/
WBA Media Relations Contact USA / Jim Cohn,
media@wba.com International, +44 (0)20 7980 8585
WBA Investor Relations Contact Tiffany Kanaga, +1 847 315
2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Apr 2024 to May 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From May 2023 to May 2024